N G Industries Ltd
₹ 118
-4.33%
29 May
- close price
About
Incorporated in 1994, N G Industries Ltd is in
the business of providing healthcare services[1]
Key Points
- Market Cap ₹ 39.6 Cr.
- Current Price ₹ 118
- High / Low ₹ 170 / 111
- Stock P/E 22.9
- Book Value ₹ 100
- Dividend Yield 2.96 %
- ROCE 5.88 %
- ROE 4.80 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.18 times its book value
Cons
- The company has delivered a poor sales growth of 6.65% over past five years.
- Company has a low return on equity of 2.00% over last 3 years.
- Earnings include an other income of Rs.1.03 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.86 | 16.93 | 17.28 | 17.36 | 17.67 | 18.50 | 11.88 | 18.42 | 18.70 | 16.88 | 16.55 | 16.39 | |
| 12.20 | 13.80 | 14.40 | 14.30 | 14.85 | 15.71 | 10.62 | 16.06 | 16.81 | 14.87 | 14.70 | 14.61 | |
| Operating Profit | 2.66 | 3.13 | 2.88 | 3.06 | 2.82 | 2.79 | 1.26 | 2.36 | 1.89 | 2.01 | 1.85 | 1.78 |
| OPM % | 17.90% | 18.49% | 16.67% | 17.63% | 15.96% | 15.08% | 10.61% | 12.81% | 10.11% | 11.91% | 11.18% | 10.86% |
| 0.53 | -0.07 | -0.02 | -0.24 | -0.34 | -0.05 | 0.14 | 1.63 | 8.37 | 4.51 | 8.00 | 1.03 | |
| Interest | 0.04 | 0.06 | 0.07 | 0.08 | 0.18 | 0.16 | 0.08 | 0.09 | 0.09 | 0.07 | 0.10 | 0.07 |
| Depreciation | 1.19 | 0.58 | 0.57 | 0.60 | 0.57 | 0.56 | 0.49 | 0.58 | 0.52 | 0.60 | 0.61 | 0.59 |
| Profit before tax | 1.96 | 2.42 | 2.22 | 2.14 | 1.73 | 2.02 | 0.83 | 3.32 | 9.65 | 5.85 | 9.14 | 2.15 |
| Tax % | 27.04% | 36.78% | 36.04% | 34.11% | 34.68% | 27.72% | 25.30% | 21.39% | 13.78% | 14.02% | 15.43% | 19.07% |
| 1.43 | 1.53 | 1.42 | 1.41 | 1.12 | 1.47 | 0.61 | 2.61 | 8.32 | 5.03 | 7.74 | 1.73 | |
| EPS in Rs | 4.27 | 4.57 | 4.24 | 4.21 | 3.34 | 4.39 | 1.82 | 7.79 | 24.83 | 15.01 | 23.10 | 5.16 |
| Dividend Payout % | 81.99% | 76.63% | 82.57% | 83.16% | 104.69% | 0.00% | 0.00% | 44.92% | 14.09% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 7% |
| 3 Years: | -4% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | 7% |
| TTM: | 568% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 20% |
| 3 Years: | 11% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 |
| Reserves | 10.99 | 11.11 | 8.97 | 8.50 | 7.62 | 5.99 | 11.66 | 20.56 | 24.85 | 32.79 | 35.17 | 30.21 |
| 1.07 | 1.17 | 1.91 | 1.48 | 1.25 | 3.02 | 0.27 | 0.51 | 0.59 | 1.18 | 1.78 | 1.61 | |
| 1.56 | 1.58 | 0.15 | 0.26 | 1.10 | 1.55 | 1.78 | 2.74 | 1.93 | 2.60 | 1.32 | 0.30 | |
| Total Liabilities | 16.97 | 17.21 | 14.38 | 13.59 | 13.32 | 13.91 | 17.06 | 27.16 | 30.72 | 39.92 | 41.62 | 35.47 |
| 5.09 | 4.87 | 4.90 | 4.96 | 5.16 | 5.26 | 5.35 | 5.56 | 5.19 | 5.62 | 5.64 | 5.13 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 8.40 | 8.89 | 4.30 | 4.24 | 3.37 | 3.84 | 8.16 | 16.15 | 22.27 | 28.95 | 31.93 | 25.98 |
| 3.48 | 3.45 | 5.18 | 4.39 | 4.79 | 4.81 | 3.55 | 5.45 | 3.26 | 5.35 | 4.05 | 4.36 | |
| Total Assets | 16.97 | 17.21 | 14.38 | 13.59 | 13.32 | 13.91 | 17.06 | 27.16 | 30.72 | 39.92 | 41.62 | 35.47 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.77 | 2.01 | 1.85 | 2.43 | 3.82 | 2.85 | 1.35 | -1.73 | 3.16 | -1.02 | 1.81 | ||
| -0.62 | -0.92 | -0.89 | -1.50 | -1.09 | -3.41 | 2.00 | 1.26 | -1.72 | 2.25 | -1.23 | ||
| -2.16 | -1.30 | -0.68 | -1.84 | -1.75 | 0.27 | -2.78 | 0.22 | -1.11 | -0.60 | -0.62 | ||
| Net Cash Flow | -1.01 | -0.21 | 0.28 | -0.91 | 0.99 | -0.29 | 0.57 | -0.25 | 0.33 | 0.63 | -0.03 | |
| Free Cash Flow | 1.49 | 1.65 | 1.25 | 1.77 | 3.04 | 2.19 | 0.77 | -2.52 | 3.02 | -2.04 | 1.16 | |
| CFO/OP | 92% | 90% | 90% | 99% | 160% | 124% | 121% | -51% | 236% | -10% | 171% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4.67 | 6.47 | 8.87 | 9.67 | 10.74 | 9.27 | 10.14 | 15.46 | 1.37 | 3.24 | 9.48 | 10.69 |
| Inventory Days | 54.21 | 55.81 | 61.32 | 58.24 | 53.13 | 41.48 | 64.81 | 155.87 | 34.69 | 52.74 | 63.96 | 69.93 |
| Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 58.87 | 62.28 | 70.19 | 67.92 | 63.87 | 50.75 | 74.95 | 171.33 | 36.05 | 55.98 | 73.44 | 80.62 |
| Working Capital Days | -43.72 | -34.93 | -14.57 | -8.41 | -19.00 | -67.08 | -32.87 | 10.50 | -24.79 | 19.24 | -20.95 | -7.79 |
| ROCE % | 11.08% | 17.98% | 16.68% | 18.80% | 18.71% | 19.77% | 6.87% | 10.68% | 6.58% | 6.56% | 5.69% | 5.88% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of materials consumed (Medical Consumables/Pharmacy Items) INR Lakhs |
|
|||||||||||
| Number of Medical Facilities (Divisions) Number |
||||||||||||
| Number of permanent employees Number |
||||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
10h - Annual Secretarial Compliance Report for FY ended 31 March 2026; no non-compliances reported.
-
Corporate Action-Board approves Dividend
1d - Board approved 32nd AGM on 26 September 2026; book closure 20-26 September, record date 19 September.
-
Board Meeting Outcome for Financial Results For Quarter And Year Ended 31St March 2026
1d - Board approved FY26 audited results, recommended Rs 3.50 dividend, AGM on 26 Sep 2026.
- Financial Results For Quarter And Year Ended 31St March, 2026 1d
-
Board Meeting Intimation for Consideration And Approval Of 1. Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2026 And 2. Dividend For The Financial Year Ended 31St March, 2026 Subject To Approval Of The Shareholders At The Ensuing AGM.
18 May - Board to meet on 28 May 2026 to approve audited FY26 results and final dividend.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
NGIL is in the healthcare business which
includes Doctor Clinics, Outpatient Services,
Diagnostic Laboratory and other Diagnostic Services, an Indoor Facility with wards and
ICU, Surgical Infrastructure, Dialysis Services, Special Clinics like Infertility, Retail Pharmacy,
Home Care Services, and an Adult Vaccination Unit